10X Capital Venture Acquisition Corp. III
DelistedCIK 1848948fmd_1RK92KQAZN0FSBDPFAJ3FKYAJ8Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Apr 01, 2021 to Sep 30, 2023, 9 periods
| Line item | FY2022 |
|---|---|
| Realized investment gains (losses) | 4 |
| Operating income | (3) |
| Other non-operating income (expense) | 4 |
| Net income | 1 |